Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
Bayer said it plans to replace glyphosate-based weed-killing ingredients in products for non-professionals in the U.S. with alternative active ingredients in order to “manage litigation risk in the U.S.,” but not due to concerns about safety.
Bayer's decision comes in response to the many lawsuits related to glyphosate that it inherited when it acquired Monsanto in 2018.
The company will replace glyphosate in the consumer lawn and garden segment with other "known and well-established active ingredients."
“We will ask the court to deny this extraordinary request to paper over glyphosate’s ecological harms only to approve it anyway down the road. Time to face the music, not run and hide.”
“It’s a slam dunk for plaintiffs. This proves these claims are viable in the tort system.”
"Will the Biden administration fix this problem, or will it allow the EPA to continue its past practice of ignoring the real-world harms of pesticides?"
Tell Home Deport and Lowe's to remove Roundup from store shelves and help protect both human and pollinators' health.
The court said that Monsanto’s argument that scientific findings about glyphosate’s links to cancer constituted a “minority view” was not supported.
Bayer will have to pay between "$8.8 billion to $9.6 billion to resolve current Roundup lawsuits."